SMTL ID : 4ccb.1

Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl)ethoxy)-5-(5-methyl-1H- pyrazol-4-yl)pyridin-2-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x OFG: 3-[(1R)-1-[5-fluoranyl-2-(1,2,3-triazol-2-yl)phenyl]ethoxy]-5-(3-methyl-1H-pyrazol-4-yl)pyridin-2-amine(Non-covalent)

OFG.1: 14 residues within 4Å: Chain A: L.38, G.39, V.46, A.64, L.112, E.113, L.114, M.115, G.118, R.169, N.170, L.172, G.185, D.186 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.38, A:L.112, A:L.172, A:L.172 Hydrogen bonds: A:E.113, A:M.115 Halogen bonds: A:N.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, Q. et al., The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib. J.Med.Chem. (2014)

Release Date

2014-01-29

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence